Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Mar-24 5:18 PM View:  | Poseida Therapeutics, Inc. (PSTX) | 01-Mar-24 | Grant | 80,743 | -- | -- | 54% 150.2K to 230.95K | |
| 04-Mar-24 5:18 PM View: | Poseida Therapeutics, Inc. (PSTX) | 01-Mar-24 | Payment of Exercise | 16,306 | $4.13 | $67,343.80 | (7%) 230.95K to 214.64K | |
| 02-Mar-23 6:26 PM View: | Poseida Therapeutics, Inc. (PSTX) | 01-Mar-23 | Grant | 92,772 | -- | -- | 166% 55.75K to 148.53K | |
| 02-Mar-23 6:26 PM View: | Poseida Therapeutics, Inc. (PSTX) | 01-Mar-23 | Payment of Exercise | 4,323 | $5.35 | $23,128.00 | (3%) 148.53K to 144.2K | |
| 01-Mar-22 7:30 PM View: | Poseida Therapeutics, Inc. (PSTX) | 01-Mar-22 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 15-Apr-19 4:08 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Apr-19 | Payment of Exercise | 2,377 | $16.54 | $39,315.60 | (3%) 68.75K to 66.37K | |
| 15-Apr-19 4:08 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Apr-19 | Option Exercise | 6,875 | -- | -- | 11% 61.88K to 68.75K | |
| 22-Feb-19 7:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-19 | Payment of Exercise | 3,939 | $16.81 | $66,214.60 | (6%) 65.81K to 61.88K | |
| 22-Feb-19 7:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-19 | Option Exercise | 11,392 | -- | -- | 21% 54.42K to 65.81K | |
| 15-Feb-19 5:34 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Feb-19 | Payment of Exercise | 2,700 | $16.54 | $44,658.00 | (5%) 57.12K to 54.42K | |
| 15-Feb-19 5:34 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Feb-19 | Option Exercise | 7,809 | -- | -- | 16% 49.31K to 57.12K | |
| 05-Feb-19 4:11 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-19 | Payment of Exercise | 5,658 | $16.12 | $91,207.00 | (10%) 54.97K to 49.31K | |
| 05-Feb-19 4:11 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-19 | Option Exercise | 15,413 | -- | -- | 39% 39.56K to 54.97K | |
| 13-Apr-18 7:15 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Apr-18 | Payment of Exercise | 2,377 | $19.37 | $46,042.50 | (6%) 41.94K to 39.56K | |
| 13-Apr-18 7:15 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Apr-18 | Option Exercise | 6,875 | -- | -- | 20% 35.06K to 41.94K | |
| 23-Feb-18 5:14 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-18 | Payment of Exercise | 3,939 | $19.28 | $75,943.90 | (10%) 39.0K to 35.06K | |
| 23-Feb-18 5:14 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-18 | Option Exercise | 11,392 | -- | -- | 41% 27.61K to 39.0K | |
| 05-Feb-18 4:27 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-18 | Payment of Exercise | 5,605 | $18.37 | $102,964.00 | (17%) 33.21K to 27.61K | |
| 05-Feb-18 4:27 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-18 | Option Exercise | 15,413 | -- | -- | 87% 17.8K to 33.21K | |
| 14-Apr-17 2:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Apr-17 | Payment of Exercise | 2,583 | $12.81 | $33,088.20 | (13%) 20.38K to 17.8K | |
| 14-Apr-17 2:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Apr-17 | Option Exercise | 6,875 | -- | -- | 51% 13.51K to 20.38K | |
| 06-Feb-17 7:01 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-17 | Payment of Exercise | 6,198 | $12.26 | $75,987.50 | (31%) 19.7K to 13.51K | |
| 06-Feb-17 7:01 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-17 | Option Exercise | 15,413 | -- | -- | 359% 4.29K to 19.7K | |
| 14-Apr-16 4:44 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Apr-16 | Payment of Exercise | 2,583 | $11.76 | $30,376.10 | (38%) 6.88K to 4.29K | |
| 14-Apr-16 4:44 PM View: | Halozyme Therapeutics, Inc. (HALO) | 13-Apr-16 | Option Exercise | 6,875 | -- | -- | 100% 0 to 6.88K | |
| 10-Aug-12 6:38 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 38,705 | $31.00 | $1,199,860.00 | (83%) 46.82K to 8.11K | |
| 10-Aug-12 6:38 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 08-Aug-12 | Disposition (other) | 8,113 | $31.00 | $251,491.00 | (100%) 8.11K to 0 | |
| 07-Mar-12 6:04 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 06-Mar-12 | Grant | 15,000 | -- | -- | 50% 30.29K to 45.29K | |
| 07-Mar-12 6:04 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 06-Mar-12 | Grant Duplicate | 1,529 | -- | -- | 3% 45.29K to 46.82K | |
| 02-Mar-12 7:46 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 01-Mar-12 | Market Sale | 1,231 | $17.11 | $21,062.40 | (4%) 31.52K to 30.29K | (< 1%) |
| 24-Feb-12 5:02 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 23-Feb-12 | Market Sale | 2,180 | $17.03 | $37,125.80 | (6%) 33.7K to 31.52K | (5%) |
| 24-Feb-12 5:02 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 22-Feb-12 | Grant | 5,800 | -- | -- | 21% 27.9K to 33.7K | |
| 10-Feb-12 8:54 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 08-Feb-12 | Grant | 5,000 | -- | -- | 22% 23.03K to 28.03K | |
| 10-Feb-12 8:54 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 08-Feb-12 | Payment of Exercise | 2,041 | $16.47 | $33,615.30 | (7%) 28.03K to 25.99K | (4%) |
| 03-Mar-11 7:05 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 01-Mar-11 | Grant | 10,000 | -- | -- | 88% 11.4K to 21.4K | |
| 03-Mar-11 7:05 PM View: | Amylin Pharmaceuticals Inc. (AMLN) | 01-Mar-11 | Grant Duplicate | 1,630 | -- | -- | 8% 21.4K to 23.03K | |
| 04-Sep-07 9:02 PM View: | Senomyx Inc. (SNMX) | 04-Sep-07 | Market Sale (Planned) | 228 | $13.25 | $3,020.66 | (< 1%) 49.16K to 48.94K | 90% |
| 16-Jul-07 7:08 PM View: | Senomyx Inc. (SNMX) | 16-Jul-07 | Market Sale (Planned) | 1,500 | $13.64 | $20,465.80 | (3%) 50.44K to 48.94K | 90% |
| 18-Jun-07 2:27 PM View: | Senomyx Inc. (SNMX) | 15-Jun-07 | Market Sale (Planned) | 10,500 | $14.84 | $155,869.00 | (17%) 60.94K to 50.44K | 91% |
| 15-May-07 8:47 PM View: | Senomyx Inc. (SNMX) | 15-May-07 | Market Sale (Planned) | 1,500 | $12.47 | $18,704.10 | (2%) 62.44K to 60.94K | 89% |
| 17-Apr-07 5:24 PM View: | Senomyx Inc. (SNMX) | 16-Apr-07 | Market Sale (Planned) | 4,752 | $13.08 | $62,151.90 | (7%) 67.19K to 62.44K | 90% |
| 16-Feb-07 10:00 PM View: | Senomyx Inc. (SNMX) | 15-Feb-07 | Market Sale (Planned) | 1,500 | $12.73 | $19,097.10 | (2%) 66.94K to 65.44K | 89% |
| 17-Jan-07 2:44 PM View: | Senomyx Inc. (SNMX) | 16-Jan-07 | Market Sale (Planned) | 1,500 | $12.83 | $19,246.20 | (2%) 68.44K to 66.94K | 90% |
| 18-Dec-06 5:27 PM View: | Senomyx Inc. (SNMX) | 15-Dec-06 | Market Sale (Planned) | 1,500 | $13.54 | $20,306.10 | (2%) 69.94K to 68.44K | 90% |
| 16-Nov-06 1:50 PM View: | Senomyx Inc. (SNMX) | 15-Nov-06 | Market Sale (Planned) | 3,000 | $14.88 | $44,649.30 | (4%) 72.94K to 69.94K | 91% |
| 18-Sep-06 1:14 PM View: | Senomyx Inc. (SNMX) | 15-Sep-06 | Market Sale (Planned) | 2,500 | $15.04 | $37,603.20 | (3%) 75.44K to 72.94K | 91% |
| 05-Sep-06 2:42 PM View: | Senomyx Inc. (SNMX) | 01-Sep-06 | Market Sale (Planned) | 954 | $14.96 | $14,271.60 | (1%) 76.39K to 75.44K | 91% |
| 15-Aug-06 6:24 PM View: | Senomyx Inc. (SNMX) | 15-Aug-06 | Market Sale (Planned) | 1,000 | $13.41 | $13,405.50 | (1%) 77.39K to 76.39K | 90% |
| 17-Jul-06 5:07 PM View: | Senomyx Inc. (SNMX) | 17-Jul-06 | Market Sale (Planned) | 1,000 | $13.11 | $13,107.00 | (1%) 78.39K to 77.39K | 90% |
| 16-Jun-06 3:36 PM View: | Senomyx Inc. (SNMX) | 15-Jun-06 | Market Sale (Planned) | 1,000 | $12.65 | $12,650.00 | (1%) 79.39K to 78.39K | 89% |